Surgery

People with HIV aren't getting the life-saving transplants they need.

He'd seen horrors as a combat surgeon, but the Haitian earthquake was worse.

NICO’s Myriad automated devices cleared for a wider range of applications.

A foot or ankle injury misdiagnosis can lead to chronic pain or arthritis.

Study shows that reducing the amount of opioids doesn't result in more pain.

Whether it's of a brick wall, sky, or nature, hospital window view doesn't really matter.

A trip to the beauty salon could result in exposure to dangerous blood-borne viruses.

Deeming Xaracoll to be a drug/device combination, the Food and Drug Administration notified Innocoll yesterday that it would not be going forward with the New Drug Application they had filed for the product in October.

The FDA has approved Adynovate (PEGylated antihemophilic factor [recombinant]) as a treatment for hemophilia A in pediatric patients under 12 years of age and for both adults and pediatric patients in the surgical setting, based on findings from a phase 3 trial.

After a review of existing studies, the FDA today sent out a warning that surgery lasting three hours or more poses a threat of brain or other neurological damage in babies, fetuses, and toddlers.

A team was able to demonstrate that spinal cord injury causes the relocation of some of the gut’s bacteria from sterile tissues to other locations throughout the body, and it appeared that these changes were linked to the activation of the immune system cells in the gut.

As the field of medical ethics continues to expand, its use can be seen in everything from general medical conditions to end of life considerations.

Following a stroke, the sooner a patient undergoes clot-busting endovascular thrombectomy, the better their outcomes are, in terms of severity of disability.

As with most surgical advances, new potential procedures in ophthalmology pose their fair share of risks. However, if those risks can be overcome the rewards to patients can make a significant difference in their quality of life.

As a retinal implant, the ARGUS II technology has shown early benefits for patients with retinitis pigmentosa. A new study from the United Kingdom is examining its benefits in patients with the dry form of age related macular degeneration.

As with all new technologies for surgical procedures, there will be questions to be answered about the safety for hypersonic vitrectomy. While human trials have not started yet, there are good indications in cadaveric and animal studies.

Medical technology is constantly evolving across fields, and ophthalmology is no exception. A new hypersonic vitrectomy device is currently in development and could be on the market in 2017.

By the time patients need a left ventricular assist device their condition has already worsened considerably. With the help of a combination of technology and medication there is some research to show that improvement is possible in many patients.

Pending further research a new powerful pharmaceutical combination could make a significant difference in the treatment of patients with a left ventricular assist device.

For patients who receive left ventricular assist device implants there is no assurance that the device will work enough for them to have a high quality of life. New research has shown a potential treatment which could make a significant improvement in this area.

As more men and women who served their country come home their skills can be put to good use in the medical community. Finding those veterans and reservists and getting them the training they need can make all the difference in their life out of uniform.

While medics and corpsmen in the military do similar jobs to what nurses do in civilian practice, those skills do not translate into certification when they leave the service.

When veterans, including medics and corpsmen come back from serving overseas their medical skills do not automatically translate into certification. Colleges and Universities are developing programs to help them and also reservists earn their bachelor of science in nursing degrees.

Researchers from the University of California-San Francisco examined patients with specific back conditions and assessed the ways in which surgery helped them with their sex lives.

The annual American Heart Association Scientific Sessions were filled with a wide range of presentations made in New Orleans. It was the late breaking news that made the most impact for those in attendance as they look to the future of cardiac care.

As the American Heart Association wrapped up another successful conference in New Orleans, each of the approximately 18,000 providers in attendance was bringing home something new to their practices or optimism for new treatments to come in the future.

Novel oral anticoagulants have made treatment of many patients considerably easier over the past few years. Finding ways to apply that to veterans can help a patient population deserving of high quality health care.

Much like civilians, military veterans have trouble maintaining safe levels with warfarin treatment.

When patients leave the waiting room of their provider, their concerns can go with them. With the help of social media channels like Facebook and Twitter, those concerns can be addressed while information is shared in a new and effective manner.

With more than 10,000 providers from around the world converging on the American Heart Association's Scientific Sessions, lessons from the event can be implemented as soon as the next day or show promise of work to come in the future.